List of Various recombination contracts products
- classification：Various recombination contracts
1～4 item / All 4 items
For those who have isolators. Achieving high chemical resistance and workability. Low cost and short delivery times are also possible for glove box and isolator gloves.
- Work gloves
Notice of participation in 'INTERPHEX Week Tokyo' from May 20 (Wednesday) to May 22 (Friday), 2026.
Ito Corporation will be exhibiting at "INTERPHEX Week Tokyo" held at Makuhari Messe. This exhibition is the largest in Japan, showcasing a wide range of products and services related to the research and manufacturing of pharmaceuticals, cosmetics, and regenerative medicine from 25 countries and regions around the world. Pharmaceutical and cosmetic manufacturers, as well as regenerative medicine companies, will be attending from all over the globe. We will be showcasing "Gloves for Glove Boxes/Isolators" manufactured by Tron Power. We look forward to your visit.
![[Presentation of Materials] Contrac...](https://image.mono.ipros.com/public/product/image/8a5/2000290828/IPROS28997239396741109507.jpeg?w=280&h=280){kind=small}
By achieving consistent DS and DP manufacturing within the same facility, the need for multiple contract management, material transportation, and technology transfer is minimized! [Exhibiting at BioPh...
- Contract manufacturing
- Other Contract Life Science Specialization
- Various recombination contracts
Libra Medicine's partner company, Mycenax Biotech Inc., has received conformity approval from the European Medicines Agency (EMA).
Our partner company, Mycenax, conducted an on-site inspection by the EMA (in January 2025) and received formal periodic synthesis approval notification in March 2025. As a result, we have completed inspections by regulatory authorities in Japan, Canada, and Europe over the last two quarters and received official "pass" notifications. 【Health Canada】 (October 2024) – Conducted a 5-day on-site inspection, completed one day ahead of schedule. Received formal "pass" notification in December 2024. 【PMDA】 (November 2024) – Conducted a 4-day on-site inspection, completed half a day ahead of schedule. Received formal "pass" notification in February 2025. 【EMA】 (January 2025) – Conducted a 10-day on-site inspection, completed two days ahead of schedule. Received formal "pass" notification in March 2025. The fact that these inspections were completed earlier than initially planned indicates that Mycenax's manufacturing facilities and quality management systems are highly regarded by international regulatory authorities.
We will assist you in the development and production of recombinant proteins (antigens, antibodies).
- Other contract manufacturing
- Various recombination contracts
- Other Protein Research
Mammalian cultured cells and the genomes of all animals can be edited!
- Various recombination contracts
- Cell-related contract
- DNA/RNA synthesis
Low-cost mass production! Contract service for recombinant protein production using recombinant rice seeds.
- Various recombination contracts
- Other contract manufacturing